GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (OTCPK:AVCNF) » Definitions » Inventories, Finished Goods

AVCNF (Avicanna) Inventories, Finished Goods : $1.74 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Avicanna Inventories, Finished Goods?

Avicanna's quarterly finished goods declined from Mar. 2024 ($1.77 Mil) to Jun. 2024 ($1.49 Mil) but then increased from Jun. 2024 ($1.49 Mil) to Sep. 2024 ($1.74 Mil).

Avicanna's annual finished goods declined from Dec. 2021 ($0.47 Mil) to Dec. 2022 ($0.42 Mil) but then increased from Dec. 2022 ($0.42 Mil) to Dec. 2023 ($1.83 Mil).

Avicanna Inventories, Finished Goods Historical Data

The historical data trend for Avicanna's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Inventories, Finished Goods Chart

Avicanna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial 0.40 0.64 0.47 0.42 1.83

Avicanna Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 1.83 1.77 1.49 1.74

Avicanna Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Avicanna Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (OTCPK:AVCNF) » Definitions » Inventories, Finished Goods
Comparable Companies
TSXV:PCLO XCNQ:TIUM.U TSXV:CANB TSXV:LSL XCNQ:GDNS TSX:LABS XCNQ:ACRG.A.U TSX:AVNT XCNQ:BNXT XCNQ:CXXI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
0NN:Germany AVCN:Canada
Address
480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2
Website
https://www.avicanna.com
Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.